000 | 01441 a2200397 4500 | ||
---|---|---|---|
005 | 20250513192446.0 | ||
264 | 0 | _c19991022 | |
008 | 199910s 0 0 fre d | ||
022 | _a0003-9683 | ||
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aChamiot-Clerc, P | |
245 | 0 | 0 |
_a[Mechanism of action of cicletanine on the relationship between endothelium and vascular smooth muscle in the rat thoracic aorta under normoxic and hypoxic conditions]. _h[electronic resource] |
260 |
_bArchives des maladies du coeur et des vaisseaux _cAug 1999 |
||
300 |
_a1027-31 p. _bdigital |
||
500 | _aPublication Type: English Abstract; Journal Article | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aAntihypertensive Agents _xtherapeutic use |
650 | 0 | 4 |
_aAorta, Thoracic _xdrug effects |
650 | 0 | 4 |
_aEndothelium, Vascular _xdrug effects |
650 | 0 | 4 |
_aIndomethacin _xpharmacology |
650 | 0 | 4 | _aLogistic Models |
650 | 0 | 4 |
_aMuscle, Smooth, Vascular _xdrug effects |
650 | 0 | 4 |
_aNitroarginine _xpharmacology |
650 | 0 | 4 |
_aOxygen _xpharmacology |
650 | 0 | 4 |
_aPyridines _xtherapeutic use |
650 | 0 | 4 | _aRats |
650 | 0 | 4 | _aRats, Wistar |
650 | 0 | 4 | _aRisk Factors |
650 | 0 | 4 |
_aVasodilator Agents _xtherapeutic use |
700 | 1 | _aChoukri, N | |
700 | 1 | _aLegrand, M | |
700 | 1 | _aSafar, M E | |
700 | 1 | _aDroy-Lefaix, M T | |
700 | 1 | _aRenaud, J F | |
773 | 0 |
_tArchives des maladies du coeur et des vaisseaux _gvol. 92 _gno. 8 _gp. 1027-31 |
|
999 |
_c10443985 _d10443985 |